Major Investors Want Bayer CEO Ousted Over Monsanto Purchase, Roundup Litigation Costs
Roundup litigation costs have made the Monsanto purchase a bad deal for shareholders and the company, the investors claim
Roundup litigation costs have made the Monsanto purchase a bad deal for shareholders and the company, the investors claim
Bayer claims the Roundup lymphoma verdict imposed excessive punitive damages and claims it is protected from liability by the EPA's decision that Roundup is safe.
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.
Bayer holds hope that a favorable Supreme Court decision will declare it exempt from Roundup lawsuits based on federal regulators' approval of the popular weed killer.